A phase II study of the HSP90 inhibitor AUY922 in chemotherapy refractory advanced pancreatic cancer - Concepedia

Concepedia

Publication | Closed Access

A phase II study of the HSP90 inhibitor AUY922 in chemotherapy refractory advanced pancreatic cancer

24

Citations

31

References

2016

Year

Daniel J. Renouf, David W. Hedley, Monika K. Krzyzanowska, Martin Schmuck, L. Wang, Malcolm J. Moore

Cancer Chemotherapy and Pharmacology

Pancreatic CancerGastrointestinal OncologyMedicinePathologyHsp90 Inhibitor Auy922Phase Ii StudyCancer TreatmentOncologyRadiation OncologyCancer ResearchChemotherapy Refractory

References

	Year	Citations

Page 1